Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey

Rhea-AI Summary

Milestone Scientific (NYSE:MLSS) has announced the commercial launch of its CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey. The center is led by Dr. Chi-Shin Jason Chiu, a double board-certified physician in Pain Management and Anesthesiology.

The CompuFlo system leverages the company's proprietary DPS Dynamic Pressure Sensing® technology, providing real-time feedback for accurate epidural space identification. Clinical studies have demonstrated the system's ability to reduce false loss of resistance, minimize complications, and improve epidural procedure success rates.

This deployment is part of Milestone Scientific's broader strategy to expand the adoption of CompuFlo across U.S. and international markets.

Positive

• Expansion into a new medical facility led by a respected pain management specialist
• Clinical studies demonstrate improved success rates and reduced complications
• Strategic advancement in the interventional pain market

Negative

• None.

Insights

Medical Device Analyst

MLSS secures strategic customer win for CompuFlo system, demonstrating commercial progress in interventional pain market.

Milestone Scientific's announcement represents a meaningful commercial advancement for their CompuFlo® Epidural System. The deployment at The Painless Center provides tangible evidence of market acceptance among specialized pain management practitioners. Particularly notable is the caliber of the adopting physician – Dr. Chi-Shin Jason Chiu brings significant credibility as a double board-certified pain specialist with academic appointments at major medical centers.

The CompuFlo system addresses a critical clinical need in epidural procedures through its proprietary DPS Dynamic Pressure Sensing® technology. By providing objective, real-time feedback during needle placement, the technology helps practitioners accurately identify the epidural space – a significant improvement over the subjective "loss of resistance" technique traditionally used. Clinical studies validate the system's ability to reduce false positives and minimize complications, key selling points for risk-averse medical institutions.

This deployment follows what the company describes as "a series of successful CompuFlo deployments" across leading institutions, suggesting growing commercial momentum. For Milestone Scientific, each new customer installation establishes a recurring revenue stream through the disposable components required for each procedure. The company's strategic focus on interventional pain represents a targeted approach to market penetration, prioritizing specialized practices where precision injection technologies deliver clear clinical value.

While a single site deployment doesn't dramatically alter the company's revenue trajectory, it demonstrates continued commercial execution and builds credibility for their ongoing sales and marketing initiatives in both domestic and international markets.

ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the initiation of commercial sales of its CompuFlo® Epidural System and related disposables at The Painless Center, located in Tenafly, New Jersey.

The Painless Center is led by Chi-Shin Jason Chiu, MD, a double board-certified physician in Pain Management and Anesthesiology. A respected figure in interventional pain medicine, Dr. Chiu is known for his compassionate care and commitment to adopting state-of-the-art technologies to improve patient outcomes. He also serves as Director of Pain Management and Anesthesia Medical Education at Newark Beth Israel Medical Center and is on the faculty at St. Barnabas Medical Center.

Neal Goldman, Chairman of the Board and Interim Chief Executive Officer of Milestone Scientific, commented, “We are pleased to announce the commercial rollout of our CompuFlo Epidural System at The Painless Center. Dr. Chiu’s reputation as a forward-thinking leader in pain management underscores the clinical value and growing appeal of our technology. His adoption of CompuFlo reflects our expanding presence within the interventional pain market and our ongoing commitment to enhancing procedural safety, efficiency, and patient satisfaction.”

The CompuFlo Epidural System utilizes Milestone Scientific’s proprietary DPS Dynamic Pressure Sensing® technology, which provides objective, real-time feedback that enables anesthesiologists and pain management physicians to accurately identify the epidural space. Clinical studies have shown the CompuFlo system can significantly reduce false loss of resistance, minimize complications, and improve the success rate of epidural procedures.

Dr. Chiu added, “At The Painless Center, we prioritize technologies that can directly enhance the safety and comfort of our patients. The CompuFlo system offers real-time confirmation during epidural injections, which helps us perform procedures with greater precision and confidence. It represents an important advancement in our practice and aligns perfectly with our patient-first philosophy.”

This announcement follows a series of successful CompuFlo deployments across leading medical institutions and interventional pain practices. Milestone Scientific continues to advance its strategic sales and marketing initiatives aimed at broadening awareness and accelerating adoption of CompuFlo throughout the U.S. and international markets.

About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient, and increase the overall patient comfort and safety. The Company leverages its proprietary DPS Dynamic Pressure Sensing Technology^® platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetics. To learn more, view the MLSS brand video or visit milestonescientific.com.

Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2024. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact:         
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020

FAQ

What is the CompuFlo® Epidural System that MLSS is selling at The Painless Center?

CompuFlo® is a computerized drug delivery system that uses DPS Dynamic Pressure Sensing® technology to provide real-time feedback during epidural procedures, helping physicians accurately identify the epidural space.

Who is leading the implementation of MLSS's CompuFlo system at The Painless Center?

Dr. Chi-Shin Jason Chiu, a double board-certified physician in Pain Management and Anesthesiology, who also serves as Director of Pain Management at Newark Beth Israel Medical Center.

What are the clinical benefits of MLSS's CompuFlo Epidural System?

Clinical studies show the system can significantly reduce false loss of resistance, minimize complications, and improve the success rate of epidural procedures.

What is Milestone Scientific's expansion strategy for the CompuFlo system?

MLSS is advancing strategic sales and marketing initiatives to broaden awareness and accelerate adoption of CompuFlo throughout U.S. and international markets.